Study Details

Back
Study ID 026-CL-006
Study Title AY4166 Long term study: Long Term Extension Study With Pioglitazone for Type 2 Diabetic Patients
Clinicaltrials.gov Identifier Not Applicable
Compound Name AY4166 / nateglinide
Medical Indication or Disease Type 2 diabetes mellitus
Study Sponsor Astellas Pharma Inc.
Collaborator Ajinomoto North America, INC.
Study Start Date 05-Oct-2005
Study Completion Date 17-Jan-2007
Clinical Study Result
Select the language
Japanese
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS